Regional variation of multiple sclerosis prevalence in Canada

Objective: To describe the regional distribution of multiple sclerosis (MS) prevalence in Canada, controlling for age and sex. Methods: This study used data from the Canadian Community Health Survey, a large general health survey (n=131,535) conducted in 2000/2001. Subjects aged 18 and over were included in the current analysis (n=116,109). The presence of MS was determined by self-report. Prevalence was computed in five regions (Atlantic, Quebec, Ontario, Prairies and British Columbia). Logistic regression was used to compare regions and examine for confounding/interaction by age and sex. Results: The overall Canadian MS prevalence was 240 per 100 000 (95%CI: 210-280). Prevalence ranged from 180 (95%CI: 90-260) in Quebec to 350 (95%CI: 230-470) in Atlantic Canada. Logistic regression revealed no statistical difference between the odds of MS in Quebec, Ontario and British Columbia adjusted for age and sex. The adjusted odds of MS in the Prairies and Atlantic regions were significantly higher than in the other regions combined, with odds ratios of 1.7 (95%CI: 1.1-2.4, p<0.01) and 1.6 (95%CI: 1.1-2.4, p<0.05) respectively. Sensitivity analysis demonstrated similar prevalence in the nonaboriginal/nonimmigrant group (n=96 219). Conclusion: Results suggest that Canadian MS prevalence differs by region. If validated, these regional differences may facilitate investigation of environmental influences.

[1]  P Oja,et al.  Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. , 1997, American journal of epidemiology.

[2]  M. C. Leske,et al.  Comparing self-reported and physician-reported medical history. , 1994, American journal of epidemiology.

[3]  Patrick Heagerty,et al.  Validation of case-mix measures derived from self-reports of diagnoses and health. , 2002, Journal of clinical epidemiology.

[4]  K. Aronson,et al.  A Systematic Review of Several Potential Non-Genetic Risk Factors for Multiple Sclerosis , 2004, Neuroepidemiology.

[5]  R. Marrie,et al.  For Personal Use. Only Reproduce with Permission from Elsevier Ltd a Complex Disease Environmental Risk Factors in Multiple Sclerosis Aetiology , 2022 .

[6]  L. Fried,et al.  Agreement Between Self‐Report of Disease Diagnoses and Medical Record Validation in Disabled Older Women: Factors That Modify Agreement , 2004, Journal of the American Geriatrics Society.

[7]  W. Pryse-Phillips,et al.  Incidence and Prevalence of Multiple Sclerosis in Newfoundland and Labrador , 2005, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[8]  G. Rosati,et al.  The prevalence of multiple sclerosis in the world: an update , 2001, Neurological Sciences.

[9]  T. Mack,et al.  Epidemiology of Multiple Sclerosis in US Veterans , 1992 .

[10]  L. Svenson,et al.  Regional variations in the prevalence rates of multiple sclerosis in the province of Alberta, Canada. , 1994, Neuroepidemiology.

[11]  N. Calonge,et al.  Validation of self-reported chronic conditions and health services in a managed care population. , 2000, American journal of preventive medicine.

[12]  G. McDonnell,et al.  High incidence and prevalence of multiple sclerosis in south east Scotland: evidence of a genetic predisposition , 1999, Journal of neurology, neurosurgery, and psychiatry.

[13]  Robert L. Shrader,et al.  Electronic communication. , 1971, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[14]  W. Pryse-Phillips.  The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960–1984 , 1986, Annals of neurology.

[15]  R. Neff,et al.  Identifying Priority Health Conditions, Environmental Data, and Infrastructure Needs: A Synopsis of the Pew Environmental Health Tracking Project , 2004, Environmental health perspectives.

[16]  M. Zins,et al.  Factors associated with self-reporting of chronic health problems in the French GAZEL cohort. , 2002, Journal of clinical epidemiology.